
Stephen L. Rawlings
Examiner (ID: 18470, Phone: (571)272-0836 , Office: P/1643 )
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1642, 1643, 1646 |
| Total Applications | 1483 |
| Issued Applications | 633 |
| Pending Applications | 153 |
| Abandoned Applications | 701 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7055627
[patent_doc_number] => 20050276800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-15
[patent_title] => 'Intrabodies'
[patent_app_type] => utility
[patent_app_number] => 11/127932
[patent_app_country] => US
[patent_app_date] => 2005-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 20030
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20050276800.pdf
[firstpage_image] =>[orig_patent_app_number] => 11127932
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/127932 | Intrabodies | May 11, 2005 | Abandoned |
Array
(
[id] => 4785016
[patent_doc_number] => 20080138345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Compositions and methods for treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/120399
[patent_app_country] => US
[patent_app_date] => 2005-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 45080
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20080138345.pdf
[firstpage_image] =>[orig_patent_app_number] => 11120399
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/120399 | Compositions and methods for treatment of cancer | May 1, 2005 | Issued |
Array
(
[id] => 7111107
[patent_doc_number] => 20050208562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/117474
[patent_app_country] => US
[patent_app_date] => 2005-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 20584
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208562.pdf
[firstpage_image] =>[orig_patent_app_number] => 11117474
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/117474 | Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof | Apr 28, 2005 | Abandoned |
Array
(
[id] => 7111108
[patent_doc_number] => 20050208563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/117475
[patent_app_country] => US
[patent_app_date] => 2005-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 21112
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208563.pdf
[firstpage_image] =>[orig_patent_app_number] => 11117475
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/117475 | Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof | Apr 28, 2005 | Abandoned |
Array
(
[id] => 5279145
[patent_doc_number] => 20090131277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'PROSTATE CANCER DIAGNOSIS AND TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 11/568089
[patent_app_country] => US
[patent_app_date] => 2005-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12995
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20090131277.pdf
[firstpage_image] =>[orig_patent_app_number] => 11568089
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/568089 | Prostate cancer diagnosis and treatment | Apr 18, 2005 | Issued |
Array
(
[id] => 5159857
[patent_doc_number] => 20070172901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Method for the evaluation of the functional status of the growth factor receptor protein expressed in malignant tumors'
[patent_app_type] => utility
[patent_app_number] => 10/599550
[patent_app_country] => US
[patent_app_date] => 2005-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4461
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20070172901.pdf
[firstpage_image] =>[orig_patent_app_number] => 10599550
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599550 | Method for the evaluation of the functional status of the growth factor receptor protein expressed in malignant tumors | Apr 4, 2005 | Abandoned |
Array
(
[id] => 5820001
[patent_doc_number] => 20060024314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Antibodies and cyclic peptides which bind CEA (carcinoembryonic antigens) and their use as cancer therapeutics'
[patent_app_type] => utility
[patent_app_number] => 11/097224
[patent_app_country] => US
[patent_app_date] => 2005-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 18001
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024314.pdf
[firstpage_image] =>[orig_patent_app_number] => 11097224
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/097224 | Antibodies and cyclic peptides which bind CEA (carcinoembryonic antigens) and their use as cancer therapeutics | Apr 3, 2005 | Abandoned |
Array
(
[id] => 7069515
[patent_doc_number] => 20050244900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Glycine N-methyltransferase monoclonal antibodies and methods of use therefor'
[patent_app_type] => utility
[patent_app_number] => 11/091504
[patent_app_country] => US
[patent_app_date] => 2005-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6065
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244900.pdf
[firstpage_image] =>[orig_patent_app_number] => 11091504
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/091504 | Glycine N-methyltransferase monoclonal antibodies and methods of use therefor | Mar 28, 2005 | Abandoned |
Array
(
[id] => 6951781
[patent_doc_number] => 20050226875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Uses of anti-CTLA-4 antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/085368
[patent_app_country] => US
[patent_app_date] => 2005-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 12302
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20050226875.pdf
[firstpage_image] =>[orig_patent_app_number] => 11085368
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/085368 | Uses of anti-CTLA-4 antibodies | Mar 20, 2005 | Abandoned |
Array
(
[id] => 7005705
[patent_doc_number] => 20050171018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Novel polypeptide and gene encoding the same'
[patent_app_type] => utility
[patent_app_number] => 11/055967
[patent_app_country] => US
[patent_app_date] => 2005-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12316
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171018.pdf
[firstpage_image] =>[orig_patent_app_number] => 11055967
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/055967 | Polypeptide and gene encoding the same | Feb 13, 2005 | Issued |
Array
(
[id] => 7184772
[patent_doc_number] => 20050191673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer'
[patent_app_type] => utility
[patent_app_number] => 11/051454
[patent_app_country] => US
[patent_app_date] => 2005-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42001
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20050191673.pdf
[firstpage_image] =>[orig_patent_app_number] => 11051454
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/051454 | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer | Feb 3, 2005 | Abandoned |
Array
(
[id] => 177694
[patent_doc_number] => 07655402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-02
[patent_title] => 'Diagnoses and therapeutics for cancer'
[patent_app_type] => utility
[patent_app_number] => 11/051679
[patent_app_country] => US
[patent_app_date] => 2005-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14317
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/655/07655402.pdf
[firstpage_image] =>[orig_patent_app_number] => 11051679
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/051679 | Diagnoses and therapeutics for cancer | Feb 3, 2005 | Issued |
Array
(
[id] => 7225501
[patent_doc_number] => 20050255118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Methods and composition for treating tumors and metastatic disease'
[patent_app_type] => utility
[patent_app_number] => 11/049365
[patent_app_country] => US
[patent_app_date] => 2005-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13470
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20050255118.pdf
[firstpage_image] =>[orig_patent_app_number] => 11049365
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/049365 | Methods and composition for treating tumors and metastatic disease | Feb 2, 2005 | Abandoned |
Array
(
[id] => 6958459
[patent_doc_number] => 20050214829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/043964
[patent_app_country] => US
[patent_app_date] => 2005-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20652
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214829.pdf
[firstpage_image] =>[orig_patent_app_number] => 11043964
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/043964 | Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof | Jan 27, 2005 | Abandoned |
Array
(
[id] => 6983305
[patent_doc_number] => 20050153375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'CEA/NCA-based differentiation cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 11/041199
[patent_app_country] => US
[patent_app_date] => 2005-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 5838
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153375.pdf
[firstpage_image] =>[orig_patent_app_number] => 11041199
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/041199 | CEA/NCA-based differentiation cancer therapy | Jan 24, 2005 | Abandoned |
Array
(
[id] => 6966456
[patent_doc_number] => 20050233353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Methods and compositions for categorizing patients'
[patent_app_type] => utility
[patent_app_number] => 11/041788
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 28062
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20050233353.pdf
[firstpage_image] =>[orig_patent_app_number] => 11041788
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/041788 | Methods and compositions for categorizing patients | Jan 20, 2005 | Abandoned |
Array
(
[id] => 7074769
[patent_doc_number] => 20050148037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Method for examining WT1-related disease'
[patent_app_type] => utility
[patent_app_number] => 11/037128
[patent_app_country] => US
[patent_app_date] => 2005-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7481
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148037.pdf
[firstpage_image] =>[orig_patent_app_number] => 11037128
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/037128 | Method for examining WT1-related disease | Jan 18, 2005 | Issued |
Array
(
[id] => 5514217
[patent_doc_number] => 20090214523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Novel anti-IL13 antibodies and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/583927
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 26574
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214523.pdf
[firstpage_image] =>[orig_patent_app_number] => 10583927
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/583927 | Anti-IL13 antibodies and uses thereof | Dec 22, 2004 | Issued |
Array
(
[id] => 7040960
[patent_doc_number] => 20050159591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Compositions and methods for the diagnosis and treatment of tumor'
[patent_app_type] => utility
[patent_app_number] => 11/021329
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 52915
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20050159591.pdf
[firstpage_image] =>[orig_patent_app_number] => 11021329
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/021329 | Compositions and methods for the diagnosis and treatment of tumor | Dec 20, 2004 | Abandoned |
Array
(
[id] => 7040956
[patent_doc_number] => 20050159588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Compositions and methods for the diagnosis and treatment of tumor'
[patent_app_type] => utility
[patent_app_number] => 11/021330
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 52915
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20050159588.pdf
[firstpage_image] =>[orig_patent_app_number] => 11021330
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/021330 | Compositions and methods for the diagnosis and treatment of tumor | Dec 20, 2004 | Abandoned |